Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-26

Clinical Trial Update: Gabapentin Versus Transdermal Fentanyl Matrix for Chronic Neuropathic Pain [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing gabapentin to a transdermal fentanyl patch for chronic neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)
  • Transdermal fentanyl matrix (fentanyl)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Neuropathic Pain, Spinal Stenosis | Phase 4 | Status: COMPLETED